Laurence Marton, Director at RenovoRx, Inc. (RNXT), bought 12,050 shares at $0.85 ($10K) on 2025-04-08, disclosed to the SEC on 2025-04-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.